Moors & Cabot, Inc.

SEC CIK: 0001607239
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

GSK holding history

GSK plc in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overview All 13F holders of GSK Full Q2 2026 holdings

Shares (Q2 2026): 20,980
Value: $1.10M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of GSK by Moors & Cabot, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	20,980	$1.10M	<0.1%	−492−2.3%	Reduced	Holders
Q1 2026	21,472	$1.19M	0.1%	−1,251−5.5%	Reduced	Holders
Q4 2025	22,723	$1.11M	<0.1%	−804−3.4%	Reduced	Holders
Q3 2025	23,527	$1.02M	<0.1%	−1,268−5.1%	Reduced	Holders
Q2 2025	24,795	$952.1K	<0.1%	−683−2.7%	Reduced	Holders
Q1 2025	25,478	$987.0K	0.1%	−1,132−4.3%	Reduced	Holders
Q4 2024	26,610	$899.9K	<0.1%	−389−1.4%	Reduced	Holders
Q3 2024	26,999	$1.10M	0.1%	−255−0.9%	Reduced	Holders
Q2 2024	27,254	$1.05M	0.1%	+1,559+6.1%	Added	Holders
Q1 2024	25,695	$1.10M	0.1%	−1,267−4.7%	Reduced	Holders
Q4 2023	26,962	$999.2K	0.1%	−1,783−6.2%	Reduced	Holders
Q3 2023	28,745	$1.04M	0.1%	−1,859−6.1%	Reduced	Holders
Q2 2023	30,604	$1.09M	0.1%	+500+1.7%	Added	Holders
Q1 2023	30,104	$1.07M	0.1%	−1,080−3.5%	Reduced	Holders
Q4 2022	31,184	$1.10M	0.1%	−156−0.5%	Reduced	Holders
Q3 2022	31,340	$922.0K	0.1%	−13,133−29.5%	Reduced	Holders
Q2 2022	44,473	$1.94M	0.1%	−387−0.9%	Reduced	Holders
Q1 2022	44,860	$1.95M	0.1%	+1,031+2.4%	Added	Holders
Q4 2021	43,829	$1.93M	0.1%	+2,133+5.1%	Added	Holders
Q3 2021	41,696	$1.60M	0.1%	+813+2.0%	Added	Holders
Q2 2021	40,883	$1.63M	0.1%	+6,670+19.5%	Added	Holders
Q1 2021	34,213	$1.23M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.